Document is current
Any future updates will be listed below
-
Authors
Schädlich, Ines Sophie
Winzer, Riekje
Stabernack, Joschi
Tolosa, Eva
Magnus, Tim https://orcid.org/0000-0001-6232-9555
Rissiek, Björn
-
Funding
Funding for this research was provided by:
Hermann und Lilly Schilling-Stiftung für Medizinische Forschung
Deutsche Forschungsgemeinschaft (335447717 - SFB 1328 A13)
Deutsche Forschungsgemeinschaft (335447717 - SFB 1328 A14)
Deutsche Forschungsgemeinschaft (335447717 - SFB 1328 Z02)
Deutsche Forschungsgemeinschaft (405358801 - FOR2879 A1)
Deutsche Forschungsgemeinschaft (405358801 - FOR2879 C1)
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 7 December 2022
Accepted: 25 January 2023
First Online: 14 March 2023
Declarations
:
: TM and BR are co-inventors on patent applications for CD73- and CD39-specific nanobodies.
